Literature DB >> 6345627

Septicaemia in a medical intensive care unit. Clinical, biochemical and microbiological data of 109 cases.

E Domínguez de Villota, A Algora, J J Rubio, M Roig, J M Mosquera, P Galdos, V Díez-Balda.   

Abstract

Blood cultures were obtained from 39% of all 574 admissions to our Medical Intensive Care Unit. (ICU); in 109 (19%) a pathogenic organism was demonstrated. 45% of the septicaemias were detected within the first 48 h of ICU stay have been considered as "non ICU-acquired". Septicaemic patients were significantly older, had longer ICU stays and a higher mortality rate (62%) than non septicaemic patients (28%) (p less than 0.05). Gram negative organisms (69%) predominated over gram positive (29%) and Serratia marcescens and coagulase positive Staphylococcus were the most frequently isolated. Shock appeared in 32% and had an extremely high mortality (91%) and was associated with the presence of "multiple species septicaemia". Prior to the septicaemia the survivors differed from the fatalities only in the level of serum albumin; this was significantly lower in patients with gram negative in comparison with gram positive septicaemias and in patients who developed shock. Arterial, pulmonary artery and urinary catheters, and endotracheal devices were used frequently in these patients and were statistically associated with the presence of septicaemia. The airway was the most frequent possible source for the septicaemia.

Entities:  

Mesh:

Year:  1983        PMID: 6345627     DOI: 10.1007/bf01772576

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  48 in total

1.  Factors predisposing to bacteriuria during indwelling urethral catheterization.

Authors:  R A Garibaldi; J P Burke; M L Dickman; C B Smith
Journal:  N Engl J Med       Date:  1974-08-01       Impact factor: 91.245

2.  Hemodynamic and metabolic studies on shock associated with gram negative bacteremia.

Authors:  H Nishijima; M H Weil; H Shubin; J Cavanilles
Journal:  Medicine (Baltimore)       Date:  1973-07       Impact factor: 1.889

3.  Editorial: Gram-negative-rod bacteremia.

Authors:  S M Wolff; J V Bennett
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

4.  Gram-negative rod bacteremia. An analysis of 100 patients.

Authors:  U G Hodgin; J P Sanford
Journal:  Am J Med       Date:  1965-12       Impact factor: 4.965

5.  Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients.

Authors:  J A Ryan; R M Abel; W M Abbott; C C Hopkins; T M Chesney; R Colley; K Phillips; J E Fischer
Journal:  N Engl J Med       Date:  1974-04-04       Impact factor: 91.245

6.  Immunocompetence of patients with protein-calorie malnutrition. The effects of nutritional repletion.

Authors:  D K Law; S J Dudrick; N I Abdou
Journal:  Ann Intern Med       Date:  1973-10       Impact factor: 25.391

7.  Complications of vascular catheterization in the critically ill. A prospective study.

Authors:  V K Puri; R W Carlson; J J Bander; M H Weil
Journal:  Crit Care Med       Date:  1980-09       Impact factor: 7.598

8.  Host resistance in sepsis and trauma.

Authors:  L D MacLean; J L Meakins; K Taguchi; J P Duignan; K S Dhillon; J Gordon
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

9.  Association of a low serum albumin with infection and increased mortality in critically ill patients.

Authors:  E Domínguez de Villota; J M Mosquera; J J Rubio; P Galdos; V Díez Balda; J L de la Serna; M I Tomás
Journal:  Intensive Care Med       Date:  1980-11       Impact factor: 17.440

Review 10.  Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.

Authors:  B E Kreger; D E Craven; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

View more
  9 in total

1.  Sequential epidemic outbreaks of septicaemias by Serratia and Klebsiella species on a medical intensive care unit.

Authors:  J L Cortés; E Domínguez-de Villota; A Algora-Weber; C Chamorro; M C Torrecilla; J M Mosquera
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

2.  The microbiologic risk of invasive haemodynamic monitoring in open-heart patients requiring prolonged ICU treatment.

Authors:  J Damen
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  A simplified technique for measuring intracranial pressure.

Authors:  F X Breheny
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

4.  Infections in critically ill patients: experience in MICU at a major teaching hospital.

Authors:  N S Dahmash; S C Arora; D F Fayed; M N Chowdhury
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

5.  Control of an epidemic spread of a multi-resistant strain of Acinetobacter calcoaceticus in a hospital.

Authors:  W H Crombach; L Dijkshoorn; M van Noort-Klaassen; J Niessen; G van Knippenberg-Gordebeke
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

6.  Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy.

Authors:  C Torrecilla; J L Cortés; C Chamorro; J J Rubio; P Galdos; E Dominguez de Villota
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

7.  The microbiology and outcome of sepsis in Victoria, Australia.

Authors:  V Sundararajan; T Korman; C Macisaac; J J Presneill; J F Cade; K Visvanathan
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

8.  Early evaluation of coagulase negative staphylococcus in blood samples of intensive care unit patients. A clinically uncertain judgement.

Authors:  E Dominguez-de Villota; A Algora-Weber; I Millán; J J Rubio; P Galdos; J M Mosquera
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

9.  Can bacteremia be predicted in surgical intensive care unit patients?

Authors:  K J Schwenzer; A Gist; C G Durbin
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.